Efficacy and safety of artificial tears containing Artemia salina extract with dinucleotides for dry eye

Clinical relevance This clinical trial was conducted as part of the marketing procedures for a medical device comprising artificial tears containing Artemia salina extract with dinucleotides. These molecules previously demonstrated secretagogue properties by enhancing the production of aqueous, mucinous, and lipidic components of the tears.